Novel Therapies in the Search for a Cure for Huntington's Disease

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2001 Jan 3

PMID 11136240

Citations 2

Authors

M F Beal

P Hantraye

Affiliations

Soon will be listed here.

Citing Articles

Efficacy and Safety of Tetrabenazine in Reducing Chorea and Improving Motor Function in Individuals With Huntington's Disease: A Systematic Review.

Vadlamani N, Ibrahimli S, Khan F, Castillo J, Amaravadi K, Nalisetty P Cureus. 2024; 16(10):e71476.

PMID: 39544557 PMC: 11560395. DOI: 10.7759/cureus.71476.

Polymeric Nanovehicle Regulated Spatiotemporal Real-Time Imaging of the Differentiation Dynamics of Transplanted Neural Stem Cells after Traumatic Brain Injury.

Wang Z, Wang Y, Wang Z, Zhao J, Gutkind J, Srivatsan A ACS Nano. 2015; 9(7):6683-95.

PMID: 26020550 PMC: 5238514. DOI: 10.1021/acsnano.5b00690.

References

Isacson O, Brundin P, Kelly P, Gage F, Bjorklund A . Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature. 1984; 311(5985):458-60. DOI: 10.1038/311458a0. View

Palfi S, Conde F, Riche D, Brouillet E, Dautry C, Mittoux V . Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med. 1998; 4(8):963-6. DOI: 10.1038/nm0898-963. View

Piccini P, Brooks D, Bjorklund A, Gunn R, Grasby P, Rimoldi O . Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci. 1999; 2(12):1137-40. DOI: 10.1038/16060. View

Lin X, Antalffy B, Kang D, Orr H, Zoghbi H . Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci. 2000; 3(2):157-63. DOI: 10.1038/72101. View

Steffan J, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu Y, Gohler H . The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A. 2000; 97(12):6763-8. PMC: 18731. DOI: 10.1073/pnas.100110097. View

Ferrante R, Andreassen O, Jenkins B, Dedeoglu A, Kuemmerle S, Kubilus J . Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci. 2000; 20(12):4389-97. PMC: 6772461. View

Chen M, Ona V, Li M, Ferrante R, Fink K, Zhu S . Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med. 2000; 6(7):797-801. DOI: 10.1038/77528. View

McCampbell A, Taylor J, Taye A, Robitschek J, Li M, Walcott J . CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet. 2000; 9(14):2197-202. DOI: 10.1093/hmg/9.14.2197. View

Freeman T, Cicchetti F, Hauser R, Deacon T, Li X, Hersch S . Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A. 2000; 97(25):13877-82. PMC: 17669. DOI: 10.1073/pnas.97.25.13877. View

10.

Bachoud-Levi A, Remy P, Nguyen J, Brugieres P, Lefaucheur J, Bourdet C . Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet. 2000; 356(9246):1975-9. DOI: 10.1016/s0140-6736(00)03310-9. View

11.

Perlow M, Freed W, Hoffer B, Seiger A, Olson L, Wyatt R . Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science. 1979; 204(4393):643-7. DOI: 10.1126/science.571147. View

12.

Bjorklund A, Stenevi U . Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res. 1979; 177(3):555-60. DOI: 10.1016/0006-8993(79)90472-4. View

13.

Bjorklund A, Stenevi U, Schmidt R, Dunnett S, Gage F . Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand Suppl. 1983; 522:9-18. View

14.

Ona V, Li M, Vonsattel J, ANDREWS L, Khan S, Chung W . Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature. 1999; 399(6733):263-7. DOI: 10.1038/20446. View

15.

Dunnett S, Whishaw I, Rogers D, Jones G . Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res. 1987; 415(1):63-78. DOI: 10.1016/0006-8993(87)90269-1. View

16.

Wictorin K, Bjorklund A . Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum--II. Cortical afferents. Neuroscience. 1989; 30(2):297-311. DOI: 10.1016/0306-4522(89)90255-8. View

17.

Wictorin K, Simerly R, Isacson O, Swanson L, Bjorklund A . Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum--III. Efferent projecting graft neurons and their relation to host afferents within the grafts. Neuroscience. 1989; 30(2):313-30. DOI: 10.1016/0306-4522(89)90256-x. View

18.

Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R . Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 1990; 247(4942):574-7. DOI: 10.1126/science.2105529. View

19.

Hantraye P, Riche D, Maziere M, Isacson O . Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci U S A. 1992; 89(9):4187-91. PMC: 525658. DOI: 10.1073/pnas.89.9.4187. View

20.

Peschanski M, Defer G, Nguyen J, Ricolfi F, Monfort J, Remy P . Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain. 1994; 117 ( Pt 3):487-99. DOI: 10.1093/brain/117.3.487. View